965 related articles for article (PubMed ID: 9824158)
1. The BCL-6 POZ domain and other POZ domains interact with the co-repressors N-CoR and SMRT.
Huynh KD; Bardwell VJ
Oncogene; 1998 Nov; 17(19):2473-84. PubMed ID: 9824158
[TBL] [Abstract][Full Text] [Related]
2. Recruitment of SMRT/N-CoR-mSin3A-HDAC-repressing complexes is not a general mechanism for BTB/POZ transcriptional repressors: the case of HIC-1 and gammaFBP-B.
Deltour S; Guerardel C; Leprince D
Proc Natl Acad Sci U S A; 1999 Dec; 96(26):14831-6. PubMed ID: 10611298
[TBL] [Abstract][Full Text] [Related]
3. The LAZ3(BCL-6) oncoprotein recruits a SMRT/mSIN3A/histone deacetylase containing complex to mediate transcriptional repression.
Dhordain P; Lin RJ; Quief S; Lantoine D; Kerckaert JP; Evans RM; Albagli O
Nucleic Acids Res; 1998 Oct; 26(20):4645-51. PubMed ID: 9753732
[TBL] [Abstract][Full Text] [Related]
4. Critical residues within the BTB domain of PLZF and Bcl-6 modulate interaction with corepressors.
Melnick A; Carlile G; Ahmad KF; Kiang CL; Corcoran C; Bardwell V; Prive GG; Licht JD
Mol Cell Biol; 2002 Mar; 22(6):1804-18. PubMed ID: 11865059
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional repression by the proto-oncogene BCL-6.
Seyfert VL; Allman D; He Y; Staudt LM
Oncogene; 1996 Jun; 12(11):2331-42. PubMed ID: 8649773
[TBL] [Abstract][Full Text] [Related]
6. Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoprotein.
Dhordain P; Albagli O; Lin RJ; Ansieau S; Quief S; Leutz A; Kerckaert JP; Evans RM; Leprince D
Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10762-7. PubMed ID: 9380707
[TBL] [Abstract][Full Text] [Related]
7. The LAZ3/BCL6 oncogene encodes a sequence-specific transcriptional inhibitor: a novel function for the BTB/POZ domain as an autonomous repressing domain.
Deweindt C; Albagli O; Bernardin F; Dhordain P; Quief S; Lantoine D; Kerckaert JP; Leprince D
Cell Growth Differ; 1995 Dec; 6(12):1495-503. PubMed ID: 9019154
[TBL] [Abstract][Full Text] [Related]
8. Characterization of receptor interaction and transcriptional repression by the corepressor SMRT.
Li H; Leo C; Schroen DJ; Chen JD
Mol Endocrinol; 1997 Dec; 11(13):2025-37. PubMed ID: 9415406
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of SMRT corepressor recruitment by the BCL6 BTB domain.
Ahmad KF; Melnick A; Lax S; Bouchard D; Liu J; Kiang CL; Mayer S; Takahashi S; Licht JD; Privé GG
Mol Cell; 2003 Dec; 12(6):1551-64. PubMed ID: 14690607
[TBL] [Abstract][Full Text] [Related]
10. BCoR, a novel corepressor involved in BCL-6 repression.
Huynh KD; Fischle W; Verdin E; Bardwell VJ
Genes Dev; 2000 Jul; 14(14):1810-23. PubMed ID: 10898795
[TBL] [Abstract][Full Text] [Related]
11. The nuclear receptor co-repressor (N-CoR) utilizes repression domains I and III for interaction and co-repression with ETO.
Lausen J; Cho S; Liu S; Werner MH
J Biol Chem; 2004 Nov; 279(47):49281-8. PubMed ID: 15377655
[TBL] [Abstract][Full Text] [Related]
12. The functional relationship between co-repressor N-CoR and SMRT in mediating transcriptional repression by thyroid hormone receptor alpha.
Choi KC; Oh SY; Kang HB; Lee YH; Haam S; Kim HI; Kim K; Ahn YH; Kim KS; Yoon HG
Biochem J; 2008 Apr; 411(1):19-26. PubMed ID: 18052923
[TBL] [Abstract][Full Text] [Related]
13. Novel BTB/POZ domain zinc-finger protein, LRF, is a potential target of the LAZ-3/BCL-6 oncogene.
Davies JM; Hawe N; Kabarowski J; Huang QH; Zhu J; Brand NJ; Leprince D; Dhordain P; Cook M; Morriss-Kay G; Zelent A
Oncogene; 1999 Jan; 18(2):365-75. PubMed ID: 9927193
[TBL] [Abstract][Full Text] [Related]
14. Functional analyses of an LXXLL motif in nuclear receptor corepressor (N-CoR).
Loinder K; Söderström M
J Steroid Biochem Mol Biol; 2004 Aug; 91(4-5):191-6. PubMed ID: 15336696
[TBL] [Abstract][Full Text] [Related]
15. Oligomerization of ETO is obligatory for corepressor interaction.
Zhang J; Hug BA; Huang EY; Chen CW; Gelmetti V; Maccarana M; Minucci S; Pelicci PG; Lazar MA
Mol Cell Biol; 2001 Jan; 21(1):156-63. PubMed ID: 11113190
[TBL] [Abstract][Full Text] [Related]
16. Gene silencing by chicken ovalbumin upstream promoter-transcription factor I (COUP-TFI) is mediated by transcriptional corepressors, nuclear receptor-corepressor (N-CoR) and silencing mediator for retinoic acid receptor and thyroid hormone receptor (SMRT).
Shibata H; Nawaz Z; Tsai SY; O'Malley BW; Tsai MJ
Mol Endocrinol; 1997 Jun; 11(6):714-24. PubMed ID: 9171235
[TBL] [Abstract][Full Text] [Related]
17. The specificity of interactions between nuclear hormone receptors and corepressors is mediated by distinct amino acid sequences within the interacting domains.
Cohen RN; Brzostek S; Kim B; Chorev M; Wondisford FE; Hollenberg AN
Mol Endocrinol; 2001 Jul; 15(7):1049-61. PubMed ID: 11435607
[TBL] [Abstract][Full Text] [Related]
18. Colocalization and heteromerization between the two human oncogene POZ/zinc finger proteins, LAZ3 (BCL6) and PLZF.
Dhordain P; Albagli O; Honore N; Guidez F; Lantoine D; Schmid M; The HD; Zelent A; Koken MH
Oncogene; 2000 Dec; 19(54):6240-50. PubMed ID: 11175338
[TBL] [Abstract][Full Text] [Related]
19. Modulation of thyroid hormone receptor silencing function by co-repressors and a synergizing transcription factor.
Lutz M; Baniahmad A; Renkawitz R
Biochem Soc Trans; 2000; 28(4):386-9. PubMed ID: 10961925
[TBL] [Abstract][Full Text] [Related]
20. TBLR1 regulates the expression of nuclear hormone receptor co-repressors.
Zhang XM; Chang Q; Zeng L; Gu J; Brown S; Basch RS
BMC Cell Biol; 2006 Aug; 7():31. PubMed ID: 16893456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
